Corporate Support
Sitemap
Singapore

ShareInvestor.com

Mobile Edition
Mode - Streaming
Switch to Static Mode?

Price Highlight

Index Highlight

Chart
STI
2,971.6
47.0 (1.61%)

 

  • STI Straits Times Index
    2,971.6
    47.0 (1.61%)
     
  • KLCI FTSE Bursa Malaysia KLCI
    1,585.4
    27.8 (1.79%)
    Index delayed 15 minutes
  • HSI Hang Seng Index
    30,138.6
    420.4 (1.41%)
    Index delayed 15 minutes
  • SSE SSE Composite Index
    3,585.0
    21.0 (0.59%)
    Index delayed 15 minutes
  • N225 Nikkei 225
    29,671.7
    -
    Index delayed 20 minutes
  • JCI Jakarta Composite Index
    6,289.8
    38.7 (0.62%)
    Index delayed 10 minutes

SGX Market

Bursa Market

HKEx Market

SET Market

IDX Market

ASX Market

NYSE Market

NASDAQ Market

NYSE American Market

  • Volume: 1,434.2M
  • Value: 1,486.2M
  • Rise: 233
  • Fall: 117
  • Unch: 426

Intraday Market Ticker Help

Intraday Market Ticker
Time Name Type Price Vol
  • Top Active

  • Top Gainer

  • Top Loser

Top Counters
Name Last Change
Thomson Medical0.115+0.006
Shen Yao0.004-
Oceanus^0.074+0.003
Jiutian Chemical0.096-
Sembcorp Marine0.155+0.003
ThaiBev0.730+0.010
Secura0.095+0.009
YZJ Shipbldg SGD1.050+0.010
ComfortDelGro1.610+0.020
SIA4.990+0.300

World Indices

World Indices
Name Last Change
Nasdaq 13,598.0 +132.8
HSI 30,121.8 +403.6
HSCEI 11,739.4 +229.7
Jakarta 6,289.6 +38.6
Nikkei 225 29,671.7
SSE Comp 3,585.0 +21.0
Shanghai A 3,758.0 +22.0
Shanghai B 245.9
KOSPI 3,099.7 +104.7

Asian Indices delayed. US Indices updated twice daily at 7:30am and 7:30pm.

Fundamental - Factsheet

Help
  • Factsheet

  • Print

IOVANCE BIOTHERAPEUTICS INC IOVANCE BIOTHERAPEUTICS
Updated on 24 Feb 2021 (End of trading day)
Last (USD): 39.420 Change: -1.180 High: 41.710 Remarks: -
Change (%): -2.91 Low: 38.520
Open 40.610 Yesterday's Close 40.6
Buy Price - Sell Price -
Buy Volume (share) - Sell Volume (share) -
Cumulative Volume (share) 1,377,548 Cumulative Value
Click to show Stock Prices chart

Key Statistics

EPS (USD) a -1.34679 Trailing EPS (USD) e -1.73670 NAV (USD) b 4.8528
PE a - Trailing PE f - Price / NAV b 8.1231
Dividend (USD) d - Cash In Hand (USD) g 0.4657 Issued & Paid-up Shares c 146,687,000
Dividend Yield (%) d - Price / Cash In Hand g 84.647 Treasury Shares h -
Market Cap (M) 5,782.402 Enterprise Value (M) 5,079.165
Piotroski F Score 0 Exchange Code IOVA Par Value ( $ ) n.a.
52 Weeks Volatility (%) 87.76 Free Float (%) 93.1
Sector & Industry Health Technology - Biotechnology
Notes:
  1. Based on latest Full Year results announcement, adjusted for the current number of shares.
  2. Based on latest results announcement (Full Year, Half Year or Interim), adjusted for carrying value of "Other Share Capital", illustrative financial effects of corporate actions (if applicable) and the current number of shares.
  3. Rounded to the nearest thousand. Updated on 09 Nov 2020.Please click here for more information.
  4. Dividend is based on latest Full Year results announcement, adjusted for current number of shares and excludes special dividend.
  5. Summation of the earnings from the latest 4 Quarter (or 2 Half Year) results announcement, adjusted for the current number of shares.
  6. Based on Trailing EPS.
  7. Based on reported cash and cash equivalents at end and extracted from the latest results announcement (Full Year, Half Year or Interim), adjusted for the current number of shares.
  8. Rounded to the nearest thousand. Updated on 28 Jun 2017.

Peer Comparison

Type Name Market Market Cap (M)a PE b Trailing PE c Price / NAV d Dividend Yield (%)d
Reference IOVANCE BIOTHERAPEUTICS INC NASDAQ 5,782.402 - - 8.1231 -
Industry Biotechnology NASDAQ 3,074.950 1438.131 - 7.3575 0.578
Local Peer AMGEN INC NASDAQ 132,834.404 18.287 18.287 14.1178 2.786
Local Peer GILEAD SCIENCES INC NASDAQ 79,892.340 649.506 649.531 4.3846 4.269
Local Peer ILLUMINA INC NASDAQ 67,267.195 102.541 102.541 14.3305 -
Local Peer MODERNA INC NASDAQ 57,294.851 - - 20.7605 -
Local Peer VERTEX PHARMACEUTICAL NASDAQ 56,421.718 20.807 20.807 6.4951 -
Local Peer REGENERON PHARMACEUTICALS INC NASDAQ 49,130.721 13.985 13.985 4.4562 -
Local Peer BIOGEN INC NASDAQ 43,071.481 10.766 10.766 4.0253 -
Local Peer ALEXION PHARMACEUTICAL INC NASDAQ 33,964.318 56.288 56.288 2.9151 -
Local Peer BEIGENE LTD SPON ADS EACH REPR 13 ORD SHS NASDAQ 30,634.978 - - 7.1452 -
Local Peer SEAGEN INC NASDAQ 28,084.043 45.764 45.764 8.0514 -
Local Peer BIONTECH SE SPON ADS EACH REP 1 ORD SHS NASDAQ 27,192.211 - - 24.9962 -
Local Peer EXACT SCIENCES CORP NASDAQ 22,797.118 - - 8.0741 -
Other Local Peers 10X GENOMICS INC (NASDAQ), ALNYLAM PHARMACEUTICALS INC (NASDAQ), INCYTE CORPORATION (NASDAQ), NOVAVAX INC (NASDAQ), BIOMARIN PHARMACEUTICAL (NASDAQ), BIO-TECHNE CORP (NASDAQ), ZAI LAB LIMITED ADS EACH REP 1 ORD SHS (NASDAQ), ABCELLERA BIOLOGICS INC (NASDAQ), CRISPR THERAPEUTICS AG (NASDAQ), NEUROCRINE BIOSCIENCES INC (NASDAQ), MIRATI THERAPEUTICS INC (NASDAQ), BRIDGEBIO PHARMA INC (NASDAQ), ULTRAGENYX PHARMACEUTICAL INC (NASDAQ), FATE THERAPEUTICS (NASDAQ), ARROWHEAD PHARMACEUTICALS INC (NASDAQ), ACCELERON PHARMA (NASDAQ), VIR BIOTECHNOLOGY INC (NASDAQ), ACADIA PHARMACEUTICALS INC (NASDAQ), IONIS PHARMACEUTICALS INC (NASDAQ), DENALI THERAPEUTICS INC (NASDAQ), PACIFIC BIOSCIENCES CALIFORNIA INC (NASDAQ), EXELIXIS INC (NASDAQ), SAREPTA THERAPEUTICS INC (NASDAQ), TWIST BIOSCIENCE CORPORATION (NASDAQ), HALOZYME THERAPEUTICS INC (NASDAQ), KODIAK SCIENCES INC (NASDAQ), TG THERAPEUTICS INC (NASDAQ), SANA BIOTECHNOLOGY INC (NASDAQ), BLUEPRINT MEDICINES CORP (NASDAQ), GALAPAGOS NV SPON ADR REPR 1 ORD SHS (NASDAQ), BEAM THERAPEUTICS INC (NASDAQ), ABCAM PLC SPON ADS EACH REP 1 ORD SHS (NASDAQ), ALLOGENE THERAPEUTICS INC (NASDAQ), FIBROGEN INC (NASDAQ), CHINA BIOLOGIC PRODUCTS HLDGS INC (NASDAQ), CHEMOCENTRYX INC (NASDAQ), ARENA PHARMACEUTICALS INC (NASDAQ), VERACYTE INC (NASDAQ), INSMED INC (NASDAQ), PTC THERAPEUTICS INC (NASDAQ), AGIOS PHARMACEUTICALS INC (NASDAQ), INTELLIA THERAPEUTICS INC (NASDAQ), RELAY THERAPEUTICS INC (NASDAQ), ARVINAS INC (NASDAQ), NANTKWEST INC (NASDAQ), MORPHOSYS SPON ADS EACH REP 0.25 ORD SHS (NASDAQ), NANOSTRING TECHNOLOGIES INC (NASDAQ), ROCKET PHARMACEUTICALS INC (NASDAQ), EDITAS MEDICINE INC (NASDAQ), SEER INC (NASDAQ), PRELUDE THERAPEUTICS INC (NASDAQ), ALKERMES PLC (NASDAQ), AMICUS THERAPEUTICS INC (NASDAQ), SORRENTO THERAPEUTICS INC (NASDAQ), GLOBAL BLOOD THERAPEUTICS INC (NASDAQ), INTRA-CELLUAR THERAPIES INC (NASDAQ), VIELA BIO INC (NASDAQ), BIONANO GENOMICS INC (NASDAQ), XENCOR INC (NASDAQ), ALLOVIR INC (NASDAQ), DECIPHERA PHARMACEUTICALS INC (NASDAQ), LIGAND PHARMACEUTICAL INC (NASDAQ), KYMERA THERAPEUTICS INC (NASDAQ), MYRIAD GENETICS INC (NASDAQ), STOKE THERAPEUTICS INC (NASDAQ), KURA ONCOLOGY INC (NASDAQ), NGM BIOPHARMACEUTICALS INC (NASDAQ), APPLIED MOLECULAR TRANSPORT INC (NASDAQ), DICERNA PHARMACEUTICALS INC. (NASDAQ), IMMUNOCORE HLDGS PLC SPON ADS EACH REP ONE ORD SHS (NASDAQ), BIOCRYST PHARMACEUTICALS INC (NASDAQ), SERES THERAPEUTICS (NASDAQ), COMPASS PATHWAYS PLC UNSPON ADS REP 1 ORD SHS (NASDAQ), AURINIA PHARMACEUTICALS INC (NASDAQ), C4 THERAPEUTICS INC (NASDAQ), NKARTA INC (NASDAQ), SANGAMO THERAPEUTICS INC (NASDAQ), BLUEBIRD BIO INC (NASDAQ), IMMUNOGEN INC (NASDAQ), TRAVERE THERAPEUTICS INC (NASDAQ), TRANSLATE BIO INC (NASDAQ), PRECIGEN INC (NASDAQ), BIOATLA INC (NASDAQ), REPLIMUNE GROUP INC (NASDAQ), REGENXBIO INC (NASDAQ), SCHOLAR ROCK HOLDING CORPORATION (NASDAQ), PURETECH HEALTH PLC SPON ADS EACH REP 10 ORD SHS (NASDAQ), IMMUNOVANT INC (NASDAQ), FREQUENCY THERAPEUTICS INC (NASDAQ), HERON THERAPEUTICS INC (NASDAQ), GRACELL BIOTECHNOLOGIES INC SPON ADS EACH REP 5 ORD SHS (NASDAQ), OCUGEN INC (NASDAQ), VOR BIOPHARMA INC (NASDAQ), UNIQURE N.V. (NASDAQ), SHATTUCK LABS INC (NASDAQ), ZENTALIS PHARMACEUTICALS INC (NASDAQ), PERSONALIS INC (NASDAQ), CYTOKINETICS INC (NASDAQ), ITEOS THERAPEUTICS INC (NASDAQ), ATARA BIOTHERAPEUTICS INC (NASDAQ), ALECTOR INC (NASDAQ), OMEROS CORP (NASDAQ), BIOXCEL THERAPEUTICS INC (NASDAQ), LUMINEX CORP(DEL) (NASDAQ), RHYTHM PHARMACEUTICALS INC (NASDAQ), MERSANA THERAPEUTICS INC (NASDAQ), ADVERUM BIOTECHNOLOGIES INC (NASDAQ), TRILLIUM THERAPEUTICS INC (NASDAQ), VAXCYTE INC (NASDAQ), MANNKIND CORPORATION (NASDAQ), PLIANT THERAPEUTICS INC (NASDAQ), MESOBLAST LTD SPON ADR EACH REP 5 SHS (NASDAQ), COHERUS BIOSCIENCES INC (NASDAQ), MACROGENICS INC (NASDAQ), FIVE PRIME THERAPEUTICS (NASDAQ), AVID BIOSERVICES INC (NASDAQ), PROTAGONIST THERAPEUTICS INC (NASDAQ), KARYOPHARM THERAPEUTICS INC (NASDAQ), 4D MOLECULAR THERAPEUTICS INC (NASDAQ), MORPHIC HOLDING INC (NASDAQ), EPIZYME INC (NASDAQ), MIMEDX GROUP INC (NASDAQ), LEXICON PHARMACEUTICALS INC (NASDAQ), ENANTA PHARMACEUTICALS INC (NASDAQ), SYNDAX PHARMACEUTICALS INC (NASDAQ), VANDA PHARMACE INC (NASDAQ), ZIOPHARM ONCOLOGY INC (NASDAQ), BLACK DIAMOND THERAPEUTICS INC (NASDAQ), TAYSHA GENE THERAPIES INC (NASDAQ), DYNAVAX TECHNOLOGIES CORP (NASDAQ), INHIBRX INC (NASDAQ), DYNE THERAPEUTICS INC (NASDAQ), AVIDITY BIOSCIENCES INC (NASDAQ), CARA THERAPEUTICS INC (NASDAQ), HUMANIGEN INC (NASDAQ), PASSAGE BIO INC (NASDAQ), CORTEXYME INC (NASDAQ), CELLECTIS ADS EACH REPR 1 ORD SPON (NASDAQ), RUBIUS THERAPEUTICS INC (NASDAQ), ADAPTIMMUNE THERAPEUTICS PLC SPON ADS EACH REP 6 ORD SHS (NASDAQ), MERIDIAN BIOSCIENCE INC COM (NASDAQ), SIGILON THERAPEUTICS INC (NASDAQ), COMPUGEN (NASDAQ), RADIUS HEALTH INC (NASDAQ), PROTHENA CORP PLC (NASDAQ), ANAVEX LIFE SCIENCES CORPORATION (NASDAQ), CHIMERIX INC (NASDAQ), SOLID BIOSCIENCES INC (NASDAQ), CURIS INC (NASDAQ), VBI VACCINES INC CDA (NASDAQ), ATHIRA PHARMA INC (NASDAQ), MERUS B V (NASDAQ), AGENUS INC (NASDAQ), KADMON HLDGS INC (NASDAQ), ASPIRA WOMENS HEALTH INC (NASDAQ), ESPERION THERAPEUTICS INC (NASDAQ), VAXART INC (NASDAQ), PANDION THERAPEUTICS INC (NASDAQ), ANAPTYSBIO INC (NASDAQ), RIGEL PHARMACEUTICALS INC (NASDAQ), IMMATICS N V (NASDAQ), MEIRAGTX HOLDINGS PLC (NASDAQ), ATRECA INC (NASDAQ), ALTIMMUNE INC (NASDAQ), MOLECULAR TEMPLATES INC (NASDAQ), POSEIDA THERAPETUICS INC (NASDAQ), ARDELYX INC (NASDAQ), AFFIMED N V (NASDAQ), AKOUOS INC (NASDAQ), SUMMIT THERAPEUTICS INC (NASDAQ), DBV TECHNOLOGIES SPON ADR EACH REPR 0.5 ORD (NASDAQ), AKEBIA THERAPEUTICS INC (NASDAQ), GERON CORP (NASDAQ), INVENTIVA SA SPON ADS EACH REP 1 ORD SHS (NASDAQ), HARPOON THERAPEUTICS INC (NASDAQ), FOGHORN THERAPEUTICS INC (NASDAQ), XENON PHARMACEUTICALS INC (NASDAQ), SYROS PHARMACEUTICALS INC (NASDAQ), PRECISION BIOSCIENCES INC (NASDAQ), FLEXION THERAPEUTICS INC (NASDAQ), XBIOTECH INC (NASDAQ), COGENT BIOSCIENCES INC (NASDAQ), IVERIC BIO INC (NASDAQ), SPECTRUM PHARMACEUTICALS INC (NASDAQ), CLOVIS ONCOLOGY INC (NASDAQ), FREELINE THERAPEUTICS HLDGS PLC SPON ADS EACH REP 1 ORD SHS (NASDAQ), AQUABOUNTY TECHNOLOGIES INC (NASDAQ), LANDOS BIOPHARMA INC (NASDAQ), ALDEYRA THERAPEUTICS (NASDAQ), HOMOLOGY MEDICINES INC (NASDAQ), BICYCLE THERAPEUTICS PLC SPON ADS EACH REP 1 ORD SHS (NASDAQ), NEOLEUKIN THERAPEUTICS INC (NASDAQ), VIKING THERAPEUTICS INC (NASDAQ), MAGENTA THERAPEUTICS INC (NASDAQ), SENSEI BIOTHERAPEUTICS INC (NASDAQ), SPRUCE BIOSCIENCES INC (NASDAQ), CYTOMX THERAPEUTICS INC (NASDAQ), UROGEN PHARMA LTD (NASDAQ), WAVE LIFE SCIENCES LTD (NASDAQ), ADICET BIO INC (NASDAQ), BIOVIE INC (NASDAQ), RAPT THERAPEUTICS INC (NASDAQ), SINOVAC BIOTECH LTD (NASDAQ), AVROBIO INC (NASDAQ), OPTHEA LIMITED SPON ADS EACH REPR 8 ORD SHS (NASDAQ), TERNS PHARMACEUTICALS INC (NASDAQ), SELECTA BIOSCIENCES INC (NASDAQ), SESEN BIO INC (NASDAQ), DECIBEL THERAPEUTICS INC (NASDAQ), AUTOLUS THERAPEUTICS PLC SPON ADS EA REP 1 ORD SHS (NASDAQ), JOUNCE THERAPEUTICS INC (NASDAQ), PUMA BIOTECHNOLOGY INC (NASDAQ), ATHERSYS INC (NASDAQ), ONCORUS INC (NASDAQ), CO DIAGNOSTICS INC (NASDAQ), MEREO BIOPHARMA GROUP PLC SPON ADS EACH REP 5 ORD SHS (NASDAQ), CUE BIOPHARMA INC (NASDAQ), VERASTEM INC (NASDAQ), GREENWICH LIFESCIENCES INC (NASDAQ), XOMA CORP (NASDAQ), CELLULAR BIOMEDICINE GROUP INC (NASDAQ), FORTE BIOSCIENCES INC (NASDAQ), UNITY BIOTECHNOLOGY INC (NASDAQ), OUTLOOK THERAPEUTICS INC (NASDAQ), SURFACE ONCOLOGY INC (NASDAQ), APTOSE BIOSCIENCES INC (NASDAQ), VISTAGEN THERAPEUTICS INC (NASDAQ), 9 METERS BIOPHARMA INC (NASDAQ), FORTRESS BIOTECH INC (NASDAQ), EIGER BIOPHARMACEUTICALS INC (NASDAQ), TREVENA INC (NASDAQ), PARATEK PHARMACEUTICALS INC (NASDAQ), ONCONOVA THERAPEUTICS INC (NASDAQ), AEGLEA BIOTHERAPEUTICS INC (NASDAQ), INNATE PHARMA SPON ADS EACH REP 1 ORD SHS (NASDAQ), CYMABAY THERAPEUTICS INC (NASDAQ), EVOFEM BIOSCIENCES INC (NASDAQ), ARBUTUS BIOPHARMA CORP (NASDAQ), T2 BIOSYSTEMS INC (NASDAQ), CASI PHARMACEUTICALS INC (NASDAQ), NEXTCURE INC (NASDAQ), CHECKMATE PHARMACEUTICALS INC (NASDAQ), TIZIANA LIFE SCIENCES PLC SPON ADS EACH REPR 10 ORD SHS (NASDAQ), BELLUS HEALTH INC (NASDAQ), IMMUNOME INC (NASDAQ), KAMADA LTD (NASDAQ), INFINITY PHARMACEUTICALS INC (NASDAQ), ITERUM THERAPEUTICS PLC (NASDAQ), NUCANA PLC SPON ADR EACH REP 1 ORD SHS (NASDAQ), MEDICINOVA INC (NASDAQ), NEPTUNE WELLNESS SOLUTIONS INC (NASDAQ), EDAP TMS S.A. SPON ADR EACH REPR 1 ORD SHARE (NASDAQ), CABALETTA BIO INC (NASDAQ), LARIMAR THERAPEUTICS INC (NASDAQ), ALPINE IMMUNE SCIENCES INC (NASDAQ), IMMUNOPRECISE ANTIBODIES LTD (NASDAQ), KEZAR LIFE SCIENCES INC (NASDAQ), AVEO PHARMACEUTICALS INC (NASDAQ), VOYAGER THERAPEUTICS INC (NASDAQ), EVOGENE LTD (NASDAQ), EQUILLIUM INC (NASDAQ), IMV INC (NASDAQ), TAIWAN LIPOSOME COMPANY LTD SPON ADS EACH REP 2 ORD SHS (NASDAQ), ADMA BIOLOGICS INC (NASDAQ), APPLIED GENETIC TECHNOLOGIES CORP (NASDAQ), INMUNE BIO INC (NASDAQ), CHIASMA INC (NASDAQ), STRONGBRIDGE BIOPHARMA PLC (NASDAQ), METACRINE INC (NASDAQ), AXCELLA HEALTH INC (NASDAQ), PROQR THERAPEUTICS N V (NASDAQ), MEDICENNA THERAPEUTICS CORP (NASDAQ), CORBUS PHARMACEUTICALS HOLDINGS IN (NASDAQ), SEELOS THERAPEUTICS INC (NASDAQ), CONCERT PHARMACEUTICALS INC (NASDAQ), CALITHERA BIOSCIENCES INC (NASDAQ), FENNEC PHARMACEUTICALS INC (NASDAQ), PLURISTEM THERAPEUTICS INC (NASDAQ), GENFIT SPON ADS EACH REP 1 ORD SHS (NASDAQ), HEAT BIOLOGICS INC (NASDAQ), ERYTECH PHARMA SPON ADR EACH REPR 1 ORD (NASDAQ), CATALYST BIOSCIENCES INC (NASDAQ), HARVARD BIOSCIENCE INC (NASDAQ), ENOCHIAN BIOSCIENCES INC (NASDAQ), DIAMEDICA THERAPEUTICS INC (NASDAQ), VTV THERAPEUTICS INC (NASDAQ), ONCOLYTICS BIOTECH INC (NASDAQ), SIO GENE THERAPIES INC (NASDAQ), ORGENESIS INC (NASDAQ), BIOFRONTERA AG SPON ADS EACH REP TWO ORD SHS (NASDAQ), GLYCOMIMETICS INC (NASDAQ), GENOCEA BIOSCIENCES INC (NASDAQ), IDERA PHARMACEUTICALS INC (NASDAQ), LIMINAL BIOSCIENCES INC (NASDAQ), AZIYO BIOLOGICS INC (NASDAQ), DYADIC INTERNATIONAL INC (NASDAQ), LEAP THERAPEUTICS INC (NASDAQ), SIERRA ONCOLOGY INC (NASDAQ), CHAMPIONS ONCOLOGY INC (NASDAQ), CONTRAFECT CORP (NASDAQ), ELOXX PHARMACEUTICALS INC (NASDAQ), X4 PHARMACEUTICALS INC (NASDAQ), LA JOLLA PHARMACEUTICAL CO (NASDAQ), APTEVO THERAPEUTICS INC (NASDAQ), BRAINSTROM CELL THERAPEUTICS (NASDAQ), PIERIS PHARMACEUTICALS INC (NASDAQ), MINERVA NEUROSCIENCES INC (NASDAQ), SYNLOGIC INC (NASDAQ), EVAXION BIOTECH AS SPON ADS EACH REP 1 ORD SHS (NASDAQ), OTONOMY INC (NASDAQ), INFLARX N V (NASDAQ), AETERNA ZENTARIS INC (NASDAQ), ARAVIVE INC (NASDAQ), IMMUTEP LTD SPON ADS EACH REP 10 ORD SHS (NASDAQ), TRACON PHARMACEUTICALS INC (NASDAQ), GALECTIN THERAPEUTICS INC (NASDAQ), ASLAN PHARMACEUTICALS LIMITED ADS EACH REP 5 ORD SHS (NASDAQ), CAPRICOR THERAPEUTICS INC (NASDAQ), AIKIDO PHARMA INC (NASDAQ), LUMOS PHARMA INC (NASDAQ), LONGEVERON INC (NASDAQ), ANIXA BIOSCIENCES INC (NASDAQ), RECRO PHARMA INC (NASDAQ), DIFFUSION PHARMACEUTICALS INC (NASDAQ), SELLAS LIFE SCIENCES GROUP INC (NASDAQ), SAVARA INC (NASDAQ), CELYAD ONCOLOGY SPON ADS EACH REPR 1 ORD SHS (NASDAQ), CIDARA THERAPEUTICS INC (NASDAQ), AVALON GLOBOCARE CORP (NASDAQ), ENTASIS THERAPEUTICS HLDGS INC (NASDAQ), NEUROBO PHARMACEUTICALS INC (NASDAQ), KAZIA THERAPEUTICS LIMITED SPON ADR EACH REP 10 ORD SHS (NASDAQ), STEALTH BIOTHERAPEUTICS CORP SPON ADS EACH REP 12 ORD SHS (NASDAQ), VASCULAR BIOGENICS LTD (NASDAQ), ADVAXIS INC (NASDAQ), CELLECTAR BIOSCIENCES INC (NASDAQ), MERRIMACK PHARMACEUTICALS INC (NASDAQ), COHBAR INC (NASDAQ), PULMATRIX INCORPORATED (NASDAQ), WINDTREE THERAPEUTICS INC (NASDAQ), VACCINEX INC (NASDAQ), MONOPAR THERAPEUTICS INC (NASDAQ), CLEVELAND BIOLABS INC (NASDAQ), ORGANOVO HLDGS INC (NASDAQ), AZURRX BIOPHARMA INC (NASDAQ), SUNESIS PHARMACEUTICALS INC (NASDAQ), ENDRA LIFE SCIENCES INC (NASDAQ), VIRIDIAN THERAPEUTICS INC (NASDAQ), APPLIED DNA SCIENCES INC (NASDAQ), BIOCARDIA INC (NASDAQ), GENETIC TECHNOLOGIES SPON ADS EA REP 600 ORD SHS(R/S) (NASDAQ), MICROBOT MEDICAL INC (NASDAQ), CATABASIS PHARMACEUTICALS INC (NASDAQ), ACORDA THERAPEUTICS INC (NASDAQ), ALTERITY THERAPEUTICS LIMITED SPON ADS EA REPR 60 ORD SHS (NASDAQ), ANPAC BIO MEDICAL SCIENCE CO LTD SPON ADS EACH REPR 1 ORD SHS CLASS A (NASDAQ), OPIANT PHARMACEUTICALS INC (NASDAQ), SOLIGENIX INC (NASDAQ), KIROMIC BIOPHARMA INC (NASDAQ), NABRIVA THERAPEUTICS PLC (NASDAQ), BIO-PATH HOLDINGS INC (NASDAQ), FORWARD PHARMA AS SPON ADS EACH REP 14 ORD SHS (NASDAQ), ALIMERA SCIENCES INC (NASDAQ), ATYR PHARMA INC (NASDAQ), PRECIPIO INC (NASDAQ), SONNET BIOTHERAPEUTICS HLDGS INC (NASDAQ), ADITX THERAPEUTICS INC (NASDAQ), ACHIEVE LIFE SCIENCE INC (NASDAQ), ARCA BIOPHARMA INC (NASDAQ), LIXTE BIOTECHNOLOGY HOLDINGS INC (NASDAQ), PHIO PHARMACEUTICALS CORP (NASDAQ), CYCLACEL PHARMACEUTICALS INC (NASDAQ), AURIS MEDICAL HOLDING LTD (NASDAQ), CYCLO THERAPEUTICS INC (NASDAQ), INMED PHARMACEUTICALS INC (NASDAQ), HISTOGEN INC (NASDAQ), HTG MOLECULAR DIAGNOSTICS INC (NASDAQ), MIDATECH PHARMA PLC SPON ADS EACH REP 5 ORD SHS(R/S) (NASDAQ), GEOVAX LABS INC (NASDAQ), ANCHIANO THERAPEUTICS LTD SPON ADS EACH REP 5 ORD SHS (NASDAQ), INVIVO THERAPEUTICS HOLDING CORP (NASDAQ), SENECA BIOPHARMA INC (NASDAQ), XENETIC BIOSCIENCES INC (NASDAQ), BELLICUM PHARMACEUTICALS (NASDAQ), SENESTECH INC (NASDAQ), BENITEC BIOPHARMA INC (NASDAQ), XTL BIOPHARMACEUTICALS LTD SPON ADS EACH REP 100 ORD SHS(POST SPLT) (NASDAQ), PLUS THERAPEUTICS INC (NASDAQ), CELLECT BIOTECHNOLOGY LTD SPON ADS EACH REP 100 ORD SHS(POST SPLT) (NASDAQ)
Global Peer CSL LTD ASX 121,921.264 38.874 32.036 11.5375 1.095
Global Peer WUXI BIO HKEx 439,539.660 382.348 305.255 29.4242 -
Global Peer BEIGENE HKEx 235,693.494 - - 7.0932 -
Global Peer SINO BIOPHARM HKEx 165,373.592 53.880 64.623 4.5884 0.607
Global Peer ZAI LAB-SB HKEx 105,012.871 - - 29.1090 -
Global Peer EMERGENT BIOSOLUTIONS INC NYSE 5,266.040 17.260 17.260 3.6393 -
Global Peer Lonza SGX 5,940.891 4.560 4.560 0.5844 5.624
Global Peer GENSCRIPT BIO HKEx 28,655.088 - - 3.9192 -
Global Peer 3SBIO HKEx 20,806.648 18.844 13.857 1.7787 -
Global Peer JW THERAP-B HKEx 17,028.533 - - -16.8021 -
Other Global Peers NUVATION BIO INC (NYSE), JACOBIO-B (HKEx), ARCUS BIOSCIENCES INC (NYSE), MYOVANT SCIENCES LTD (NYSE), VIVA BIOTECH (HKEx), ALPHAMAB-B (HKEx), HAOHAI BIOTEC (HKEx), FRONTAGE (HKEx), POLYNOVO LIMITED (ASX), JHBP-B (HKEx), MESOBLAST LTD (ASX), ASCENTAGE-B (HKEx), TELIX PHARMACEUTIC (ASX), KINTOR PHARMA-B (HKEx), ACTINIUM PHARMACEUTICALS INC (NYSE American), DPHARMA (Bursa), SINOMAB BIO-B (HKEx), SQZ BIOTECHNOLOGIES CO (NYSE), OPTHEA LIMITED (ASX), ASCLETIS-B (HKEx), LEE'S PHARM (HKEx), IMUGENE LIMITED (ASX), 22ND CENTURY GROUP INC (NYSE American), LINEAGE CELL THERAPEUTICS INC (NYSE American), ANTEOTECH LIMITED (ASX), ESSEX BIO-TECH (HKEx), NANOVIRICIDES INC (NYSE American), BIONOMICS LTD (ASX), NEXT SCIENCE LTD (ASX), IMMUTEP LTD (ASX), IBIO INC (NYSE American), CEL-SCI CORP (NYSE American), ENZO BIOCHEM INC (NYSE), KAZIA THERAPEUTICS LIMITED (ASX), NEUREN PHARMACEUTICALS LTD (ASX), PALATIN TECHNOLOGIES INC (NYSE American), MATINAS BIOPHARMA HOLDINGS INC (NYSE American), ARMATA PHARMACEUTICALS INC (NYSE American), UNI-BIO GROUP (HKEx), AIM IMMUNOTECH INC (NYSE American), SYNTHETIC BIOLOGICS INC (NYSE American), LEAF RESOURCES LTD (ASX), GENETIC TECHNOLOGIES (ASX), CHIMERIC THERAPEUTICS LTD (ASX), REGENT PACIFIC (HKEx), CYNATA THERAPEUTICS LTD (ASX), ALTERITY THERAPEUTICS LIMITED (ASX), MEMPHASYS LTD (ASX), ORAGENICS INC (NYSE American), INDIA GLOBALIZATION CAPITAL INC (NYSE American), PRESCIENT THERAPEUTICS LIMITED (ASX), INVEX THERAPEUTICS LTD NPV (ASX), CT ENTERPRISE (HKEx), PATRYS LIMITED (ASX), BIOTRON (ASX), CAN FITE BIOPHARMA LTD SPON ADS EA REP 30 ORD SHS(POST REV SPL (NYSE American), AUSTRALIAN PRIMARY HEMP LTD (ASX), AVECHO BIOTECHNOLOGY LTD (ASX), ADALTA LTD (ASX), Suntar Eco-City (SGX), CONSTELLATION TECHNOLOGIES LTD (ASX), CONTANGO ASSET MANAGEMENT LIMITED (ASX), REGENEUS LTD (ASX), RHINOMED LIMITED (ASX), AMPLIA THERAPEUTICS LTD (ASX), ACTINOGEN MEDICAL LTD (ASX), NOVABAY PHARMACEUTICALS INC (NYSE American), NEUROSCIENTIFIC BIOPHARMA LTD (ASX), HOLISTA COLLTECH LIMITED (ASX), ANATARA LIFESCIENCES LTD (ASX), NANOLLOSE LTD (ASX), CRYOSITE (ASX), LIVING CELL TECHNOLOGIES (ASX), FACTOR THERAPEUTICS LIMITED (ASX)
Notes:
  1. For companies, Market Cap is based on the trading currency of the company. Industry/Index Market Cap is the average market cap for that industry/index.
  2. Industry/Index PE is calculated using (Total Market Cap/Total Earnings) of all companies in the industry/index.
  3. Industry/Index Price/NAV is calculated using (Total Market Cap/Total Shareholders' Equity) of all companies in the industry/index.
  4. Industry/Index Dividend Yield is calculated using (Total Gross Dividend/Total Market Cap) of all companies in the industry/index.
  5. For Industry/Index calculation, data for foreign currency denominated companies will be converted to the main market currency using the latest exchange rate.
  6. Industry/Index/Peers data is updated daily.
  7. Peers are sorted by market capitalisation and only details for the top 10 will be shown.

Total Shareholder Return

PeriodDividend ReceivedCapital AppreciationTotal Shareholder Return
Short Term Return 5 Days --6.980
-15.04 %
10 Days --8.330
-17.45 %
20 Days --4.230
-9.69 %
Medium Term Return 3 Months -+1.480
+3.90 %
6 Months -+10.200
+34.91 %
1 Year -+6.390
+19.35 %
Long Term Return 2 Years -+29.150
+283.84 %
3 Years -+21.270
+117.19 %
Annualised Return Annualised --
+29.50 %
Notes:
  1. Total Shareholder Return (TSR) combines share price appreciation and dividends paid to show the total return to the shareholder expressed as a percentage.
  2. Script dividends are ignored in this calculation.

Price Movements

1 Year Range 18.700 - 54.208 Change From 1 Year Low +20.720 % Change From 1 Year Low (%) +110.80
Change From 1 Year High -14.788 % Change From 1 Year High (%) -27.28
2 Years Range 9.210 - 54.208 Change From 2 Years Low +30.210 % Change From 2 Years Low (%) +328.01
Change From 2 Years High -14.788 % Change From 2 Years High (%) -27.28
5 Years Range 4.450 - 54.208 Change From 5 Years Low +34.970 % Change From 5 Years Low (%) +785.84
Change From 5 Years High -14.788 % Change From 5 Years High (%) -27.28
Notes:
  1. Price movements are based on adjusted historical data.

Company Background

Iovance Biotherapeutics, Inc. operates as a biotechnology company. The firm engages in the development and commercialization of novel cancer immunotherapy products. Its lead product candidate, LN-144 for metastatic melanoma, is an autologous adoptive cell therapy utilizing tumor-infiltrating lymphocytes, or TIL, which are T cells derived from patients' tumors. The company was founded by Robert T. Brooke on September 17, 2007 and is headquartered in San Carlos, CA.

Historical Price Data

Date Open High Low Close Volume VWAP
24 Feb 2021 40.610 41.710 38.520 39.420 1,377,548 -
23 Feb 2021 41.460 41.530 38.030 40.600 2,243,634 -
22 Feb 2021 46.360 46.710 42.730 43.000 1,215,282 -
19 Feb 2021 47.310 47.500 46.180 47.190 758,621 -
18 Feb 2021 46.450 46.790 44.000 46.400 1,173,969 -
17 Feb 2021 46.800 47.760 44.750 47.520 1,507,630 -
16 Feb 2021 48.790 49.020 47.170 47.300 1,084,433 -
12 Feb 2021 47.940 48.370 46.730 47.570 800,527 -
11 Feb 2021 49.290 49.770 47.460 47.750 778,269 -
10 Feb 2021 51.170 52.283 48.380 48.550 871,898 -
09 Feb 2021 51.170 52.450 50.270 50.560 934,444 -
08 Feb 2021 50.280 53.040 49.650 52.590 1,069,907 -
05 Feb 2021 49.170 50.140 48.690 49.650 634,113 -
04 Feb 2021 47.170 48.880 46.540 48.680 625,993 -
03 Feb 2021 48.060 48.150 46.300 46.730 907,437 -
02 Feb 2021 44.890 47.730 44.470 47.350 1,182,082 -
01 Feb 2021 44.150 44.540 43.190 44.020 776,110 -
29 Jan 2021 44.010 44.710 42.500 43.840 1,218,284 -
28 Jan 2021 42.480 44.500 41.960 43.650 1,297,871 -
27 Jan 2021 43.890 44.990 41.060 42.580 1,697,204 -
26 Jan 2021 46.700 47.300 44.526 44.610 1,076,743 -
25 Jan 2021 47.620 48.000 44.620 46.510 1,395,045 -
Summary
Current 2 Weeks
(10 Feb 2021 to 24 Feb 2021)
51.170 52.283 38.030 39.420 11,811,811 -
Previous 2 Weeks
(27 Jan 2021 to 09 Feb 2021)
43.890 52.283 38.030 50.560 10,343,445 -
4 Weeks from
(28 Dec 2020 to 26 Jan 2021)
50.190 52.283 38.030 44.610 23,705,479 -
View All Historical Data

More Information Available

More information is available to our subscribers, including:

  • Market Moving News from Dow Jones Newswires
  • Consensus Estimates
  • Dividend/Distribution History
  • Financial Summary with Financial Period Comparison
  • Comprehensive Financial Ratios(ROA, ROE, Price/Revenue, Net Earnings Margin, Current Ratio, Debt to Equity Ratio etc)
  • Events Calendar for Results Announcements, Ex-Dates etc
  • Insider Buying and Selling Report

If you are an existing subscriber, please login. If not, read up on what you are missing out in our Help Centre and join us as a subscriber.

Disclaimer:

While reasonable efforts have been taken to ensure that the calculations performed by the features of this site are reliable, the features are provided on the basis that:-

  1. no liability is accepted for any errors or inaccuracies resulting from your use of these features;
  2. many of the data inputs (including share prices) are obtained from third party sources for which we assume no responsibility.
We use Cookies. By continuing to use this webite, you will be agreeing to our Privacy Policy, Terms and Conditions and Cookie Policy.